Cellecta is a biotech company developing advanced high-throughput genetic screen technologies for the discovery and functional characterization of novel therapeutic targets and drugs.
Cellecta is a biotech company developing advanced high-throughput genetic screen technologies for the discovery and functional characterization of novel therapeutic targets and drugs.
DNA-directed RNA Interference (ddRNAi) is Benitec’s RNAi platform for gene silencing, with several advantages over other methods of gene silencing such as siRNA, anti-sense and zinc finger nucleases.
DLVR Therapeutics is developing an innovative, HDL-like Peptide-Phospholipid Scaffold (HPPS) nanoparticle delivery system, initially for RNAi therapeutics.
Ascletis is a biotech company dedicated to discovering and developing new treatments against cancer and infectious diseases using RNAi biotechnology.